The role of sphingolipids in neuronal development: Lessons from models of sphingolipid storage diseases

Neurochemical Research

Volumn 27, Issue 7-8, 2002, Pages 565-574

  Buccoliero, Rosaria ^a   Bodennec, Jacques ^a   Futerman, Anthony H ^a  

^a WEIZMANN INSTITUTE OF SCIENCE   (Israel)

Author keywords

Ceramide; Ganglioside; Gaucher disease; Glucosylceramide; Hippocampal neurons; Niemann Pick disease; Sandhoff disease

Indexed keywords

CERAMIDE; GANGLIOSIDE; GANGLIOSIDE GD 1A; GANGLIOSIDE GM3; GLUCOSYLCERAMIDE; SPHINGOLIPID; SPHINGOSINE;

ARTICLE; BRAIN LEVEL; CELL DEATH; CELL DIFFERENTIATION; CELL GROWTH; CELL MIGRATION; GAUCHER DISEASE; GENE EXPRESSION REGULATION; LIPID METABOLISM; LIPOGENESIS; LYSOSOME STORAGE DISEASE; MYELINATION; NERVE GROWTH; NIEMANN PICK DISEASE; NONHUMAN; PRIORITY JOURNAL; SANDHOFF DISEASE;

ANIMALS; BRAIN; HUMANS; LIPID METABOLISM, INBORN ERRORS; MODELS, BIOLOGICAL; NEURONS; SPHINGOLIPIDS;

ANIMALIA;

EID: 0036695808     PISSN: 03643190     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1020207613196     Document Type: Article

References (91)

1. Perry, D. K. and Hannun, Y. A. 1998. The role of ceramide in cell signaling. Biochim. Biophys. Acta 1436:233-243.
2. Riboni, L., Viani, P., Bassi, R., Prinetti, A., and Tettamanti, G. 1997. The role of sphingolipids in the process of signal transduction. Prog. Lipid Res. 36:153-195.
3. Ando, S. 1983. Gangliosides in the nervous system. Neurochem. Int. 5:507-537.
4. Yu, R. K. and Saito, M. 1989. Structure and Localization of Gangliosides. Pages 174-187, in Margolis, R. U., and Margolis, R. K. (Eds.), Neurobiology of Glycoconjugates, Plenum, New York.
5. Ledeen, R. W. and Yu, G. 1992. Ganglioside function in the neuron. Trends Glycosci. Glycotechnol. 4:174-187.
6. Schwarz, A. and Futerman, A. H. 1996. The localization of gangliosides in neurons of the central nervous system: the use of anti-ganglioside antibodies. Biochim. Biophys. Acta 1286: 247-267.
7. Facci, L., Leon, A., Toffano, G., Sonnino, S., Ghidoni, R., and Tettamanti, G. 1984. Promotion of neuritogenesis in mouse neuroblastoma cells by exogenous gangliosides. Relationship between the effect and the cell association of ganglioside GM1. J. Neurochem. 42:299-305.
8. Walkley, S. U., Siegel, D. A., Dobrenis, K., and Zervas, M. 1998. GM2 ganglioside as a regulator of pyramidal neuron dendritogenesis. Ann. N.Y. Acad. Sci. 845:188-199.
9. Walkley, S. U., Zervas, M., and Wiseman, S. 2000. Gangliosides as modulators of dendritogenesis in normal and storage disease-affected pyramidal neurons. Cereb. Cortex 10:1028-1037.
10. Leon, A., Facci, L., Toffano, G., Sonnino, S., and Tettamanti, G. 1981. Activation of (Na+, K+)-ATPase by nanomolar concentrations of GM1 ganglioside. J. Neurochem. 37:350-357.
11. Bassi, R., Chigorno, V., Fiorilli, A., Sonnino, S., and Tettamanti, G. 1991. Exogenous gangliosides GD1b and GD1b-lactone, stably associated to rat brain P2 subcellular fraction, modulate differently the process of protein phosphorylation. J. Neurochem. 57:1207-1211.
12. Hakomori, S. 1990. Bifunctional role of glycosphingolipids. Modulators for transmembrane signaling and mediators for cellular interactions. J. Biol. Chem. 265:18713-18716.
13. Schnaar, R. L. 1991. Glycosphingolipids in cell surface recognition. Glycobiology 1:477-485.
14. Dotti, C. G., Sullivan, C. A., and Banker, G. A. 1988. The establishment of polarity by hippocampal neurons in culture. J. Neurosci. 8:1454-1468.
15. Goslin, K., Asmussen, H., and Banker, G. (1998) Pages 339-370, in Banker, G., and Goslin, K. (eds), Culturing Nerve Cells, MIT press, Cambridge, MA.
16. Futerman, A. H. 1998. The roles of ceramide in the regulation of neuronal growth and development. Biochemistry (Moscow) 63:74-83.
17. Futerman, A. H., Boldin, S., Brann, A. B., Schwarz, A., and Zisling, R. 1998. Regulatory roles for sphingolipids in the growth of polarized neurons. Ann. N. Y. Acad. Sci. 845:176-187.
18. Futerman, A. H. 1998. Distinct roles for sphingolipids and glycosphingolipids at different stages of neuronal development. Acta Biochim. Pol. 45:469-478.
19. Futerman, A. H., Boldin, S. A., Brann, A. B., Pelled, D., Meivar-Levy, I., and Zisling, R. 1999. Regulation of sphingolipid and glycosphingolipid metabolism during neuronal growth and development. Biochem. Soc. Trans. 27:432-437.
20. Svennerholm, L., Bostrom, K., Fredman, P., Mansson, J.E., Rosengren, B., and Rynmark, B. M. 1989. Human brain gangliosides: developmental changes from early fetal stage to advanced age. Biochim. Biophys. Acta 1005:109-117.
21. Hirabayashi, Y., Hyogo, A., Nakao, T., Tsuchiya, K., Suzuki, Y., Matsumoto, M., Kon, K., and Ando, S. 1990. Isolation and characterization of extremely minor gangliosides, GM1b and GD1 alpha, in adult bovine brains as developmentally regulated antigens. J. Biol. Chem. 265:8144-8151.
22. Sonnino, S., Bassi, R., Chigorno, V., and Tettamanti, G. 1990. Further studies on the changes of chicken brain gangliosides during prenatal and postnatal life. J. Neurochem. 54:1653-1660.
23. Rosner, H., al-Aqtum, M., and Rahmann, H. 1992. Gangliosides and neuronal differentiation. Neurochem. Int. 20:339-351.
24. Yu, R. K. 1994. Development regulation of ganglioside metabolism. Prog. Brain Res. 101:31-44.
25. Levine, J. M., Beasley, L., and Stallcup, W. B. 1984. The D1.1 antigen: a cell surface marker for germinal cells of the central nervous system. J. Neurosci. 4:820-831.
26. Mendez-Otero, R., Schlosshauer, B., Barnstable, C. J., and Constantine-Paton, M. 1988. A developmentally regulated antigen associated with neural cell and process migration. J. Neurosci. 8:564-579.
27. Kotani, M., Kawashima, I., Ozawa, H., Terashima, T., and Tai, T. 1993. Differential distribution of major gangliosides in rat central nervous system detected by specific monoclonal antibodies. Glycobiology 3:137-146.
28. Yu, R. K. and Ando, S. 1980. Structures of some new complex gangliosides of fish brain. Adv. Exp. Med. Biol. 125:33-45.
29. Rosner, H. 1982. Ganglioside changes in the chicken optic lobes as biochemical indicators of brain development and maturation. Brain Res. 236:49-61.
30. Yu, R. K., Macala, L. J., Taki, T., Weinfield, H. M., and Yu, F. S. 1988. Developmental changes in ganglioside composition and synthesis in embryonic rat brain. J. Neurochem. 50: 1825-1829.
31. Suzuki, K., Poduslo, S. E., and Norton, W. T. 1967. Gangliosides in the myelin fraction of developing rats. Biochim. Biophys. Acta 144:375-381.
32. Suzuki, K. 1970. Formation and turnover of myelin ganglioside. J. Neurochem. 17:209-213.
33. Saito, M. and Yu, R. K. 1992. Role of myelin-associated neuraminidase in the ganglioside metabolism of rat brain myelin. J. Neurochem. 58:83-87.
34. Saito, M., Tanaka, Y., Tang, C. P., Yu, R. K., and Ando, S. 1995. Characterization of sialidase activity in mouse synaptic plasma membranes and its age-related changes. J. Neurosci. Res. 40:401-406.
35. Banker, G. A. and Cowan, W. M. 1977. Brain Res. 126: 397-425.
36. Hirschberg, K., Zisling, R., van Echten-Deckert, G., and Futerman, A. H. 1996. Ganglioside synthesis during the development of neuronal polarity. Major changes occur during axonogenesis and axon elongation, but not during dendrite growth or synaptogenesis. J. Biol. Chem. 271:14876-14882.
37. Harel, R. and Futerman, A. H. 1993. Inhibition of sphingolipid synthesis affects axonal outgrowth in cultured hippocampal neurons. J. Biol. Chem. 268:14476-14481.
38. Schwarz, A., Rapaport, E., Hirschberg, K., and Futerman, A. H. 1995. A regulatory role for sphingolipids in neuronal growth. Inhibition of sphingolipid synthesis and degradation have opposite effects on axonal branching. J. Biol. Chem. 270:10990-10998.
39. Schwarz, A. and Futerman, A. H. 1997. Distinct roles for ceramide and glucosylceramide at different stages of neuronal growth. J. Neurosci. 17:2929-2938.
40. Takamiya, K., Yamamoto, A., Furukawa, K., Yamashiro, S., Shin, M., Okada, M., Fukumoto, S., Haraguchi, M., Takeda, N., Fujimura, K., Sakae, M., Kishikawa, M., Shiku, H., and Aizawa, S. 1996. Mice with disrupted GM2/GD2 synthase gene lack complex gangliosides but exhibit only subtle defects in their nervous system. Proc. Natl. Acad. Sci. U. S. A. 93:10662-10667.
41. Takamiya, K., Yamamoto, A., Furukawa, K., Zhao, J., Fukumoto, S., Yamashiro, S., Okada, M., Haraguchi, M., Shin, M., Kishikawa, M., Shiku, H., and Aizawa, S. 1998. Complex gangliosides are essential in spermatogenesis of mice: possible roles in the transport of testosterone. Proc. Natl. Acad. Sci. U. S. A. 95:12147-12152.
42. Sheikh, K. A., Sun, J., Liu, Y., Kawai, H., Crawford, T. O., Proia, R. L., Griffin, J. W., and Schnaar, R. L. 1999. Mice lacking complex gangliosides develop Wallerian degeneration and myelination defects. Proc. Natl. Acad. Sci. U. S. A. 96: 7532-7537.
43. Liu, Y., Hoffmann, A., Grinberg, A., Westphal, H., McDonald, M. P., Miller, K. M., Crawley, J. N., Sandhoff, K., Suzuki, K., and Proia, R. L. 1997. Mouse model of GM2 activator deficiency manifests cerebellar pathology and motor impairment. Proc. Natl. Acad. Sci. U. S. A. 94:8138-8143.
44. Sango, K., McDonald, M. P., Crawley, J. N., Mack, M. L., Tifft, C. J., Skop, E., Starr, C. M., Hoffmann, A., Sandhoff, K., Suzuki, K., and Proia, R. L. 1996. Mice lacking both subunits of lysosomal beta-hexosaminidase display gangliosidosis and mucopolysaccharidosis. Nat. Genet. 14:348-352.
45. Yamanaka, S., Johnson, M. D., Grinberg, A., Westphal, H., Crawley, J. N., Taniike, M., Suzuki, K., and Proia, R. L. 1994. Targeted disruption of the Hexa gene results in mice with biochemical and pathologic features of Tay-Sachs disease. Proc. Natl. Acad. Sci. U. S. A. 91:9975-9979.
46. Liu, Y., Suzuki, K., Reed, J. D., Grinberg, A., Westphal, H., Hoffmann, A., Doring, T., Sandhoff, K., and Proia, R. L. 1998. Mice with type 2 and 3 Gaucher disease point mutations generated by a single insertion mutagenesis procedure. Proc. Natl. Acad. Sci. U. S. A. 95:2503-2508.
47. Yamashita, T., Wada, R., Sasaki, T., Deng, C., Bierfreund, U., Sandhoff, K., and Proia, R. L. 1999. A vital role for glycosphingolipid synthesis during development and differentiation. Proc. Natl. Acad. Sci. U. S. A. 96:9142-9147.
48. Mansson, J. E., Vanier, M. T., and Svennerholm, L. 1978. Changes in the fatty acid and sphingosine composition of the major gangliosides of human brain with age. J. Neurochem. 30:273-275.
49. Palestini, P., Sonnino, S., and Tettamanti, G. 1991. Lack of the ganglioside molecular species containing the C20-long-chain bases in human, rat, mouse, rabbit, cat, dog, and chicken brains during prenatal life. J. Neurochem. 56:2048-2050.
50. Valsecchi, M., Palestini, P., Chigomo, V., Sonnino, S., and Tettamanti, G. 1993. Changes in the ganglioside long-chain base composition of rat cerebellar granule cells during differentiation and aging in culture. J. Neurochem. 60:193-196.
51. Sonnino, S. and Chigorno, V. 2000. Ganglioside molecular species containing C18- and C20-sphingosine in mammalian nervous tissues and neuronal cell cultures. Biochim. Biophys. Acta 1469:63-77.
52. Valsecchi, M., Chigorno, V., Sonnino, S., and Tettamanti, G. 1992. Rat cerebellar granule cells in culture associate and metabolize differently exogenous GM1 ganglioside molecular species containing a C18 or C20 long chain base. Chem. Phys. Lipids 60:247-252.
53. Chigorno, V., Negroni, E., Nicolini, M., and Sonnino, S. 1997. Activity of 3-ketosphinganine synthase during differentiation and aging of neuronal cells in culture. J. Lipid Res. 38:1163-1169.
54. Boldin, S. and Futerman, A. H. 1997. Glucosylceramide synthesis is required for basic fibroblast growth factor and laminin to stimulate axonal growth. J. Neurochem. 68:882-885.
55. Brann, A. B., Tcherpakov, M., Williams, I. M., Futerman, A. H., and Fainzilber, M. 2002. NGF-induced p75-mediated death of cultured hippocampal neurons is age-dependent and transduced through ceramide generated by neutral sphingomyelinase. J. Biol. Chem. (in press).
56. Brann, A. B., Scott, R., Neuberger, Y., Abulafia, D., Boldin, S., Fainzilber, M., and Futerman, A. H. 1999. Ceramide signaling downstream of the p75 neurotrophin receptor mediates the effects of nerve growth factor on outgrowth of cultured hippocampal neurons. J. Neurosci. 19:8199-8206.
57. Pelled, D., Raveh, T., Riebeling, C., Fridkin, M., Berissi, H., Futerman, A. H., and Kimchi, A. 2001. Death-protein- (DAP) kinase plays a central role in ceramide-induced apoptosis in cultured hippocampal neurons. J. Biol. Chem. 277:1957-1961.
58. Uemura, K., Sugiyama, E., and Taketomi, T. 1991. Effects of an inhibitor of glucosylceramide synthase on glycosphingolipid synthesis and neurite outgrowth in murine neuroblastoma cell lines. J. Biochem. (Tokyo) 110:96-102.
59. Furuya, S., Ono, K., and Hirabayashi, Y. 1995. Sphingolipid biosynthesis is necessary for dendrite growth and survival of cerebellar Purkinje cells in culture. J. Neurochem. 65:1551- 1561.
60. Schwarz, A. and Futerman, A. H. 1998. Inhibition of sphingolipid synthesis, but not degradation, alters the rate of dendrite growth in cultured hippocampal neurons. Brain Res. Dev. Brain Res. 108:125-130.
61. Boldin, S. A. and Futerman, A. H. 2000. Up-regulation of glucosylceramide synthesis upon stimulation of axonal growth by basic fibroblast growth factor. Evidence for post-translational modification of glucosylceramide synthase. J. Biol. Chem. 275: 9905-9909.
62. Weinstein, D. C. and Hemmati-Brivanlou, A. 1999. Neural induction. Annu. Rev. Cell Dev. Biol. 15:411-433.
63. Radin, N. S. 1994. Rationales for cancer chemotherapy with PDMP, a specific inhibitor of glucosylceramide synthase. Mol. Chem. Neuropathol. 21:111-127.
64. Radin, N. S. 2001. Killing cancer cells by poly-drug elevation of ceramide levels: a hypothesis whose time has come? Eur. J. Biochem. 268:193-204.
65. Sprong, H., Degroote, S., Claessens, T., van Drunen, J., Oorschot, V., Westerink, B. H., Hirabayashi, Y., Klumperman, J., van der Sluijs, P., and van Meer, G. 2001. Glycosphingolipids are required for sorting melanosomal proteins in the Golgi complex. J. Cell Biol. 155:369-380.
66. Korkotian, E., Schwarz, A., Pelled, D., Schwarzmann, G., Segal, M., and Futerman, A. H. 1999. Elevation of intracellular glucosylceramide levels results in an increase in endoplasmic reticulum density and in functional calcium stores in cultured neurons. J. Biol. Chem. 274:21673-21678.
67. Dawkins, J. L., Hulme, D. J., Brahmbhatt, S. B., Auer-Grumbach, M., and Nicholson, G. A. 2001. Mutations in SPTLC1, encoding serine palmitoyltransferase, long chain base subunit-1, cause hereditary sensory neuropathy type I. Nat. Genet. 27:309-312.
68. Bejaoui, K., Wu, C., Scheffler, M. D., Haan, G., Ashby, P., Wu, L., de Jong, P., and Brown, R. H., Jr. 2001. SPTLC1 is mutated in hereditary sensory neuropathy, type 1. Nat. Genet. 27: 261-262.
69. Walkley, S. U. 1988. Pathobiology of neuronal storage disease. Int. Rev. Neurobiol. 29:191-244.
70. Walkley, S. U., Baker, H. J., and Rattazzi, M. C. 1990. Initiation and growth of ectopic neurites and meganeurites during postnatal cortical development in ganglioside storage disease. Brain Res. Dev. Brain Res. 51:167-178.
71. Walkley, S. U., Wurzelmann, S., Rattazzi, M. C., and Baker, H. J. 1990. Distribution of ectopic neurite growth and other geometrical distortions of CNS neurons in feline GM2 gangliosidosis. Brain Res. 510:63-73.
72. Walkley, S. U. 1998. Cellular pathology of lysosomal storage disorders. Brain Pathol. 8:175-193.
73. Purpura, D. P. and Suzuki, K. 1976. Distortion of neuronal geometry and formation of aberrant synapses in neuronal storage disease.: Brain Res. 116:1-21.
74. Ledeen, R. W. 1984. Biology of gangliosides: neuritogenic and neuronotrophic properties. J. Neurosci. Res. 12:147-159.
75. Vanier, M. T. 1999. Lipid changes in Niemann-Pick disease type C brain: personal experience and review of the literature. Neurochem. Res. 24:481-489.
76. Zervas, M., Dobrenis, K., and Walkley, S. U. 2001. Neurons in Niemann-Pick disease type C accumulate gangliosides as well as unesterified cholesterol and undergo dendritic and axonal alterations. J. Neuropathol. Exp. Neurol. 60:49-64.
77. Vogler, C., Barker, J., Sands, M. S., Levy, B., Galvin, N., and Sly, W. S. 2001. Murine mucopolysaccharidosis VIL: impact of therapies on the phenotype, clinical course, and pathology in a model of a lysosomal storage disease. Pediatr. Dev. Pathol. 4:421-433.
78. Kyle, J. W., Birkenmeier, E. H., Gwynn, B., Vogler, C., Hoppe, P. C., Hoffmann, J. W., and Sly, W. S. 1990. Correction of murine mucopolysaccharidosis VII by a human beta-glucuronidase transgene. Proc. Natl. Acad. Sci. U. S. A. 87: 3914-1918.
79. Shull, R. M., Munger, R. J., Spellacy, E., Hall, C. W., Constantopoulos, G., and Neufeld, E. F. 1982. Canine alpha-L-iduronidase deficiency. A model of mucopolysaccharidosis I. Am. J. Pathol. 109:244-248.
80. March, P. A., Thrall, M. A., Brown, D. E., Mitchell, T. W., Lowenthal, A. C., and Walkley, S. U. 1997. GABAergic neuroaxonal dystrophy and other cytopathological alterations in feline Niemann-Pick disease type C. Acta Neuropathol. (Berlin) 94:164-172.
81. Zervas, M., Somers, K. L., Thrall, M. A., and Walkley, S. U. 2001. Critical role for glycosphingolipids in Niemann-Pick disease type C. Curr. Biol. 11: 1283-1287.
82. Liu, Y., Wu, Y. P., Wada, R., Neufeld, E. B., Mullin, K. A., Howard, A. C., Pentchev, P. G., Vanier, M. T., Suzuki, K., and Proia, R. L. 2000. Alleviation of neuronal ganglioside storage does not improve the clinical course of the Niemann-Pick C disease mouse. Hum. Mol. Genet. 9:1087-1092.
83. Liu, Y., Wada, R., Kawai, H., Sango, K., Deng, C., Tai, T., McDonald, M. P., Araujo, K., Crawley, J. N., Bierfreund, U., Sandhoff, K., Suzuki, K., and Proia, R. L. 1999. A genetic model of substrate deprivation therapy for a glycosphingolipid storage disorder. J. Clin. Invest. 103:497-505.
84. Nilsson, O. and Svennerholm, L. 1982. Accumulation of glucosylceramide and glucosylsphingosine (psychosine) in cerebrum and cerebellum in infantile and juvenile Gaucher disease. J. Neurochem. 39:709-718.
85. Orvisky, E., Sidransky, E., McKinney, C. E., Lamarca, M. E., Samimi, R., Krasnewich, D., Martin, B. M., and Ginns, E. I. 2000. Glucosylsphingosine accumulation in mice and patients with type 2 Gaucher disease begins early in gestation. Pediatr. Res. 48:233-237.
86. Kobayashi, T., Goto, I., Okada, S., Orii, T., Ohno, K., and Nakano, T. 1992. Accumulation of lysosphingolipids in tissues from patients with GM1 and GM2 gangliosidoses. J. Neurochem. 59:1452-1458.
87. Suzuki, K. 1988. Twenty five years of the "psychosine hypothesis": a personal perspective of its history and present status. Neurochem. Res. 23:251-259.
88. Atsumi, S., Nosaka, C., Iinuma, H., and Umezawa, K. 1993. Accumulation of tissue glucosylsphingosine in Gaucher-like mouse induced by the glucosylceramidase inhibitor cyclophellitol. Arch. Biochem. Biophys. 304:302-304.
89. Igisu, H., Hamasaki, N., Ito, A., and Ou, W. 1988. Inhibition of cytochrome c oxidase and hemolysis caused by lysosphingolipids. Lipids 23:345-348.
90. Hannun, Y. A. and Bell, R. M. 1987. Lysosphingolipids inhibit protein kinase C: implications for the sphingolipidoses. Science 235:670-674.
91. Sohal, P. S. and Cornell, R. B. 1990. Sphingosine inhibits the activity of rat liver CTP:phosphocholine cytidylyltransferase. J. Biol. Chem. 265:11746-11750.